SCHEMBL13209409

SCHEMBL13209409

CCC(C)OCc1ccc(Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 4/20 0.47
AGXT P21549 2/20 0.47
PPARG P37231 2/20 0.46
PPARA Q07869 2/20 0.46
CHRNB2 P17787 1/20 0.45
CHRNA4 P43681 1/20 0.45
HPGD P15428 1/20 0.44
HTT P42858 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A3 Q01959 1/20 0.44
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
MMP2 P08253 1/20 0.41
CA9 Q16790 1/20 0.41
MAOB P27338 3/20 0.39
APP P05067 1/20 0.39
FFAR1 O14842 1/20 0.38
CYP19A1 P11511 1/20 0.38
SLC6A4 P31645 1/20 0.38
MAOA P21397 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8012380 0.89 IDO1 (0.40) IDO1AGXTPPARGPPARACHRNB2
SCHEMBL19121409 0.83 TDP1 (0.38) IDO1HPGDCA2
SCHEMBL17227254 0.82 CHRNA4 (0.56) IDO1AGXTPPARGPPARACHRNB2
SCHEMBL18579549 0.82 CHRNA4 (0.56) IDO1AGXTPPARGPPARACHRNB2
SCHEMBL13694098 0.82 ACACB (0.36) IDO1AGXTPPARGPPARASLC6A2
SCHEMBL9070613 0.82 AGXT (0.48) IDO1AGXTCA1CA2CA9
SCHEMBL10819594 0.81 IDO1 (0.52) IDO1AGXTPPARGPPARACHRNB2
SCHEMBL23634056 0.80 IDO1 (0.47) IDO1AGXTMAOBAPP
SCHEMBL4689685 0.80 IDO1 (0.47) IDO1HPGDMAOBAPP
SCHEMBL28072230 0.79 PPARG (0.47) IDO1AGXTPPARGPPARACHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210363119-A1 PROTEASOME INHIBITORS NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION 2021-11-25 US disclosed
US-9810821-B2 Infrared ray cutoff filter FUJIFILM CORPORATION (JP) 2017-11-07 US disclosed
US-20150293281-A1 CURABLE RESIN COMPOSITION FOR FORMING INFRARED REFLECTIVE FILM, INFRARED REFLECTIVE FILM AND MANUFACTURING METHOD THEREOF, INFRARED RAY CUT-OFF FILTER, AND SOLID-STATE IMAGING DEVICE USING THE SAME FUJIFILM CORPORATION (JP) 2015-10-15 US disclosed
US-7781519-B2 Solubilizer and composition containing same KUREHA CORPORATION (JP) 2010-08-24 US disclosed
US-20070244221-A1 Solubilizer and Composition Containing Same KUREHA CORPORATION (JP) 2007-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210363119-A1 PROTEASOME INHIBITORS TP53, CDKN1A, PSME1 IDO1 3047/4885AGXT 3879/4885PPARG 3346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.